260 related articles for article (PubMed ID: 27291397)
1. Multiple myeloma: practice patterns across Europe.
Raab MS; Cavo M; Delforge M; Driessen C; Fink L; Flinois A; Gonzalez-McQuire S; Safaei R; Karlin L; Mateos MV; Schoen P; Yong K
Br J Haematol; 2016 Oct; 175(1):66-76. PubMed ID: 27291397
[TBL] [Abstract][Full Text] [Related]
2. Multiple myeloma: patient outcomes in real-world practice.
Yong K; Delforge M; Driessen C; Fink L; Flinois A; Gonzalez-McQuire S; Safaei R; Karlin L; Mateos MV; Raab MS; Schoen P; Cavo M
Br J Haematol; 2016 Oct; 175(2):252-264. PubMed ID: 27411022
[TBL] [Abstract][Full Text] [Related]
3. Real-world treatment patterns and associated progression-free survival in relapsed/refractory multiple myeloma among US community oncology practices.
Jagannath S; Roy A; Kish J; Lunacsek O; Globe D; Eaddy M; Kuriakose ET; Willey J; Butler-Bird S; Siegel D
Expert Rev Hematol; 2016 Jul; 9(7):707-17. PubMed ID: 27291638
[TBL] [Abstract][Full Text] [Related]
4. Real-world treatment patterns and outcomes in non-transplant newly diagnosed multiple Myeloma in France, Germany, Italy, and the United Kingdom.
Mohty M; Knauf W; Romanus D; Corman S; Verleger K; Kwon Y; Cherepanov D; Cambron-Mellott MJ; Vikis HG; Gonzalez F; Gavini F; Ramasamy K
Eur J Haematol; 2020 Sep; 105(3):308-325. PubMed ID: 32418256
[TBL] [Abstract][Full Text] [Related]
5. Recent real-world treatment patterns and outcomes in US patients with relapsed/refractory multiple myeloma.
Bruno AS; Willson JL; Opalinska JM; Nelson JJ; Lunacsek OE; Stafkey-Mailey DR; Willey JP
Expert Rev Hematol; 2020 Sep; 13(9):1017-1025. PubMed ID: 32844683
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment of multiple myeloma in Germany: analysis of a nationwide multi-institutional survey.
Merz M; Kellermann L; Poenisch W; Tischler HJ; Kohnke J; Knauf W; Goldschmidt H
Ann Hematol; 2017 Jun; 96(6):987-993. PubMed ID: 28409228
[TBL] [Abstract][Full Text] [Related]
7. Understanding mortality in multiple myeloma: Findings of a European retrospective chart review.
Mohty M; Cavo M; Fink L; Gonzalez-McQuire S; Leleu H; Mateos MV; Raab MS; Schoen P; Yong K
Eur J Haematol; 2019 Aug; 103(2):107-115. PubMed ID: 31112311
[TBL] [Abstract][Full Text] [Related]
8. Going the distance: Are we losing patients along the multiple myeloma treatment pathway?
Terpos E; Suzan F; Goldschmidt H
Crit Rev Oncol Hematol; 2018 Jun; 126():19-23. PubMed ID: 29759561
[TBL] [Abstract][Full Text] [Related]
9. Real‑world multiple myeloma management practice patterns and outcomes in selected Central and Eastern European countries.
Coriu D; Dytfeld D; Niepel D; Spicka I; Markuljak I; Mihaylov G; Ostojic-Kolonic S; Fink L; Toka KS; Björklöf K
Pol Arch Intern Med; 2018 Sep; 128(9):500-511. PubMed ID: 30057386
[TBL] [Abstract][Full Text] [Related]
10. Evolution of diagnostic workup and treatment for multiple myeloma 2013-2019.
Schjesvold F
Eur J Haematol; 2020 Oct; 105(4):434-448. PubMed ID: 32557833
[TBL] [Abstract][Full Text] [Related]
11. Real-world treatment patterns, healthcare resource use and disease burden in patients with multiple myeloma in Europe.
Martínez-Lopez J; Bailey A; Lambert A; Luke E; Ribbands A; Erler-Yates N; Valluri S; Haefliger B; Gay F
Future Oncol; 2023 Oct; 19(31):2103-2121. PubMed ID: 37706245
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of Second-Line Treatment for Patients With Multiple Myeloma in the Connect MM Registry (2010-2016).
Jagannath S; Abonour R; Durie BGM; Gasparetto C; Hardin JW; Narang M; Terebelo HR; Toomey K; Wagner L; Srinivasan S; Kitali A; Yue L; Flick ED; Agarwal A; Rifkin RM
Clin Lymphoma Myeloma Leuk; 2018 Jul; 18(7):480-485.e3. PubMed ID: 29844008
[TBL] [Abstract][Full Text] [Related]
13. Productivity losses in patients with newly diagnosed multiple myeloma following stem cell transplantation and the impact of maintenance therapy.
Jackson G; Galinsky J; Alderson DEC; D'Souza VK; Buchanan V; Dhanasiri S; Walker S
Eur J Haematol; 2019 Oct; 103(4):393-401. PubMed ID: 31325331
[TBL] [Abstract][Full Text] [Related]
14. How to treat multiple myeloma: thoughts on a multicentre survey in Germany.
Bladé J; Rosiñol L; Cibeira MT; de Larrea CF
Onkologie; 2010; 33(11):577-8. PubMed ID: 20975302
[No Abstract] [Full Text] [Related]
15. Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study.
Cavo M; Tacchetti P; Patriarca F; Petrucci MT; Pantani L; Galli M; Di Raimondo F; Crippa C; Zamagni E; Palumbo A; Offidani M; Corradini P; Narni F; Spadano A; Pescosta N; Deliliers GL; Ledda A; Cellini C; Caravita T; Tosi P; Baccarani M;
Lancet; 2010 Dec; 376(9758):2075-85. PubMed ID: 21146205
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.
Gay F; Oliva S; Petrucci MT; Conticello C; Catalano L; Corradini P; Siniscalchi A; Magarotto V; Pour L; Carella A; Malfitano A; Petrò D; Evangelista A; Spada S; Pescosta N; Omedè P; Campbell P; Liberati AM; Offidani M; Ria R; Pulini S; Patriarca F; Hajek R; Spencer A; Boccadoro M; Palumbo A
Lancet Oncol; 2015 Dec; 16(16):1617-29. PubMed ID: 26596670
[TBL] [Abstract][Full Text] [Related]
17. Estimate of multiple myeloma patients by line of therapy in the USA: population-level projections 2020-2025.
Kanas G; Clark O; Keeven K; Nersesyan K; Sansbury L; Hogea C
Future Oncol; 2021 Mar; 17(8):921-930. PubMed ID: 33200616
[No Abstract] [Full Text] [Related]
18. Treatment of Non-transplant patients with multiple myeloma: routine treatment by office-based haematologists in Germany--data from the prospective Tumour Registry Lymphatic Neoplasms (TLN).
Knauf W; Abenhardt W; Aldaoud A; Nusch A; Grugel R; Münz M; Hartmann H; Marschner N;
Oncol Res Treat; 2014; 37(11):635-6, 638-44. PubMed ID: 25486127
[TBL] [Abstract][Full Text] [Related]
19. Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland.
Samaras P; Bargetzi M; Betticher DC; Duchosal MA; Heim D; Hess U; Ketterer N; Lerch E; Matthes T; Mey U; Pabst T; Taverna C; Zander T; Renner C
Swiss Med Wkly; 2015; 145():w14100. PubMed ID: 25999239
[TBL] [Abstract][Full Text] [Related]
20. Real-world study on adoption of standard-of-care for transplant-eligible newly diagnosed multiple myeloma patients between 2017 and 2020/2021 across France, Germany, Spain, and Italy.
Weisel K; Wadlund AO; Gungor G; Dergarabetian E; Pacheco C; Masurkar N; Rodriguez-Otero P
Eur J Haematol; 2022 Oct; 109(4):388-397. PubMed ID: 35775385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
